Answers are grounded in this paper and cite their sources.
ICD implantation remains the most effective strategy for sudden death prevention in ARVC, but requires careful risk stratification due to long-term complications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zorzi et al. (2014) conducted a review in Arrhythmogenic right ventricular cardiomyopathy (ARVC). Diagnostic and therapeutic pathways (ICD, ablation, pharmacological therapy) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: